1-(Methoxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(3-fluorophenyl)propanoic acid, 97%, 250mg

4-Iodophenoxyacetic Acid>97.0%(GC)25g

1-[2-(3,4-dimethoxyphenyl)ethyl]-5-oxopyrrolidine-3-carboxylic acid, 5g

(R)-4-Bromostyrene oxide, 97.0%, 1g

1-Bromo-5-fluoro-2-iodo-3-methylbenzene, 95+%, 1g

4-(5-Chloro-2-thienyl)-4-oxobutyric acid, 95.0%, 25g

Thalidomide-NH-C6-NH2 (TFA), 100mg

4,6-DIFLUORO-1H-INDAZOLE, 95%, 100mg

ethyl 5-(4-ethylphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

Iodocyclopropane, 95%, 5g

4-Bromo-2-iodoaniline, 95.0%, 5g

3-G1 2AB (500pmol/vial)1vial